Follow The Filings

BLBD Blue Bird Corporation

Consumer Discretionary, filed as BLUE BIRD CORP (COM), Equity As of 2026 Q1 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.2%
  • $1.1M
  • 1 reduce

In 2026 Q1 Robert Olstein trimmed Blue Bird.

Who owns this now

Largest portfolio weights among holders, up to 0.2% (Robert Olstein, Olstein Capital Management). Not free-float ownership.

  1. Robert Olstein Reduce 0.24%

Who owns BLBD

Sorted by value, long equity only, as of 2026 Q1.

History
Robert Olstein, Olstein Capital Management 0.24% Reduce −15.1% 19,526 $1.1M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by BLBD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BLBD insider trades
  • $62K bought by 1 insider
  • $1.6M sold by 3 insiders outside a trading plan
  • $764K sold by 1 insider under 10b5-1 plans
  1. Jeffrey Scott Sanfrey COO
    Sale
    $250K 4,000 shares at $62.40 10% of stake
    Traded Sep 16 Filed Sep 18
  2. Daniel Mark Thau Director
    Buy
    $23K 350 shares at $64.37 +4% to stake
    Traded Aug 12 Filed Aug 13
  3. Daniel Mark Thau Director
    Buy
    $20K 300 shares at $65.09 +3.6% to stake
    Traded May 19 Filed May 20
  4. Jeffrey Scott Sanfrey COO
    Sale
    $304K 5,192 shares at $58.54 12% of stake
    Traded Mar 4 Filed Mar 5
  5. Razvan Radulescu CFO
    Sale
    $239K 3,925 shares at $60.98 8.5% of stake
    Traded Feb 19 Filed Feb 20
  6. Razvan Radulescu CFO
    Planned sale
    $361K 7,006 shares at $51.58 13% of stake
    Traded Dec 17, 2025 Filed Dec 17, 2025
  7. Phil Horlock Director
    Sale
    $775K 15,381 shares at $50.42 6.4% of stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
  8. Razvan Radulescu CFO
    Planned sale
    $402K 7,984 shares at $50.39 14% of stake
    Traded Dec 10, 2025 Filed Dec 10, 2025
  9. Daniel Mark Thau Director
    Buy
    $20K 400 shares at $51.05 +7% to stake
    Traded Dec 4, 2025 Filed Dec 5, 2025

Also filed in the last 12 months, not counted as buying or selling: 17 stock grants, 10 share withholdings for taxes, and 3 option exercises.

Congress

1 member of Congress traded BLBD in the last three years: 0 buys and 1 sale. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Julie Johnson D-TX-32Joint Sell $1K–$15K Apr 7, 2025 filed May 14, 2025

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 5.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 1.01,2.03,7.01,9.01
424B7
8-K 8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 1.01,7.01,9.01
8-K 2.02,7.01,9.01
10-Q
8-K 1.01,9.01
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
10-Q
8-K/A 5.02
SCHEDULE 13G —
SCHEDULE 13D —
8-K 2.01,3.02,5.02,5.03,7.01,9.01
SCHEDULE 13G/A —
8-K 5.02,5.07,9.01
8-K 1.01,7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.13B $1.35B $1.48B
Gross profit $138.85M $256.16M $303.51M
Gross margin * 12.3% 19.0% 20.5%
Net income $23.81M $105.55M $127.72M
Net margin * 2.1% 7.8% 8.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $236.06M $323.38M $411.63M
Total non-current assets * $181.7M $201.52M $213.63M
Total assets $417.77M $524.89M $625.26M
Total current liabilities $229.62M $235.97M $236.8M
Total non-current liabilities $148.15M $129.36M $133.04M
Total equity $40M $159.56M $255.42M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $119.93M $111.11M $176.21M
Cash from investing -$8.52M -$15.82M -$23.87M
Cash from financing -$42.9M -$46.6M -$50.72M
Net change in cash $68.51M $48.7M $101.63M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf